AVAGLIANO MARK (Chief Business Officer) sold 1.1% of their position (2.64K shares) of G1 THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2024ACC: 0001562180-24-005657
Officer· Chief Business Officer
Since Jul 2019
-2.64K
Net shares
Net seller
$6.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.64K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.64K
Price / share
$2.51
Trade value
$6.62K
% of position
1.1%
7/5/2024
244.68K→242.04K
Total
Net shares
−2.64K
Net value
-$6.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/5/2024 | S · Sale | −2.64K | $2.51 | $6.62K | 1.1% | 244.68K | 242.04K |
| Total | −2.64K | -$6.62K | ||||||
Derivative Transactions0
No derivative transactions reported